Journal of Clinical Endocrinology & Metabolism, Vol 72, 560-566, Copyright © 1991 by Endocrine Society

ARTICLES

A new cause of female pseudohermaphroditism: placental aromatase deficiency

M Shozu, K Akasofu, T Harada and Y Kubota
Department of Obstetrics and Gynecology, Kanazawa University School of Medicine, Japan.

A description is presented of the first documented case of placental aromatase deficiency. The deficiency caused maternal virilization during pregnancy and pseudohermaphroditism of the female fetus. A 24-yr- old primigravida showed progressive virilization during the third trimester. Urinary excretion of estrogen was less than 14 mumol/day between 35-38 weeks of pregnancy, although nonstress tests showed reactive patterns and serum levels of human placental lactogen were above 460 nmol/L. Maternal serum levels of estrogens were low, and those of androgens were high in the third trimester. A dehydroepiandrosterone sulfate loading test induced a marked increase in maternal serum levels of androgens, whereas no such increase was observed in estrogens. The woman delivered vaginally a live full-term infant who exhibited female pseudohermaphroditism. Cord serum levels of estrogens were extremely low, while those of androgens were high. The aromatase activity of the placenta, determined by the conversion of [7- 3H]androstenedione to 17 beta-[7-3H]estradiol and [7-3H]estrone, were less than 0.03 fmol/microgram protein.min (control, 9.6 +/- 2.2 fmol/microgram protein.min). The sulfatase activity of the placenta was 0.63 pmol/microgram protein.min compared to 0.46 +/- 0.16 pmol/microgram protein.min in controls. The rate of aromatization by normal control placentas was the same as that obtained during coincubation of samples of normal placentas and that of the patient. Thus, the presence of aromatase inhibitor in the patient's placenta was excluded.

This article has been cited by other articles:

				L. Lin, O. Ercan, J. Raza, C. P. Burren, S. M. Creighton, R. J. Auchus, M. T. Dattani, and J. C. Achermann Variable Phenotypes Associated with Aromatase (CYP19) Insufficiency in Humans J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 982 - 990. [Abstract] [Full Text] [PDF]

				C. J. Corbin, S. M. Mapes, J. Marcos, C. H. Shackleton, D. Morrow, S. Safe, T. Wise, J. J. Ford, and A. J. Conley Paralogues of Porcine Aromatase Cytochrome P450: A Novel Hydroxylase Activity Is Associated with the Survival of a Duplicated Gene Endocrinology, May 1, 2004; 145(5): 2157 - 2164. [Abstract] [Full Text] [PDF]

				A L Ogilvy-Stuart and C E Brain Early assessment of ambiguous genitalia Arch. Dis. Child., May 1, 2004; 89(5): 401 - 407. [Full Text] [PDF]

				I. Marshall, F. Ugrasbul, F. Manginello, M. P. Wajnrajch, C. H. L. Shackleton, M. I. New, and M. V. Vogiatzi Congenital Hypopituitarism as a Cause of Undetectable Estriol Levels in the Maternal Triple-Marker Screen J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4144 - 4148. [Abstract] [Full Text] [PDF]

				O. Pinhas-Hamiel, Y. Zalel, E. Smith, R. Mazkereth, A. Aviram, S. Lipitz, and R. Achiron Prenatal Diagnosis of Sex Differentiation Disorders: The Role of Fetal Ultrasound J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4547 - 4553. [Abstract] [Full Text] [PDF]

				N. C. Zachos, R. B. Billiar, E. D. Albrecht, and G. J. Pepe Developmental Regulation of Baboon Fetal Ovarian Maturation by Estrogen Biol Reprod, October 1, 2002; 67(4): 1148 - 1156. [Abstract] [Full Text] [PDF]

				S. N. Kalantaridou and G. P. Chrousos Monogenic Disorders of Puberty J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2481 - 2494. [Full Text] [PDF]

				S. Sebastian and S. E. Bulun A Highly Complex Organization of the Regulatory Region of the Human CYP19 (Aromatase) Gene Revealed by the Human Genome Project J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4600 - 4602. [Full Text] [PDF]

				E. F.-L. Chiang, Y.-L. Yan, Y. Guiguen, J. Postlethwait, and B.-c. Chung Two Cyp19 (P450 Aromatase) Genes on Duplicated Zebrafish Chromosomes Are Expressed in Ovary or Brain Mol. Biol. Evol., April 1, 2001; 18(4): 542 - 550. [Abstract] [Full Text] [PDF]

				E. R. Simpson Genetic Mutations Resulting in Loss of Aromatase Activity in Humans and Mice Reproductive Sciences, January 1, 2000; 7(1_suppl): S18 - S21. [Abstract] [PDF]

				Estrogen: Consequences and Implications of Human Mutations in Synthesis and Action J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4677 - 4694. [Abstract] [Full Text]

				J. Deladoëy, C. Flück, M. Bex, N. Yoshimura, N. Harada, and P. E. Mullis Aromatase Deficiency Caused by a Novel P450arom Gene Mutation: Impact of Absent Estrogen Production on Serum Gonadotropin Concentration in a Boy J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4050 - 4054. [Abstract] [Full Text]

				C. J. Corbin, J. M. Trant, K. W. Walters, and A. J. Conley Changes in Testosterone Metabolism Associated with the Evolution of Placental and Gonadal Isozymes of Porcine Aromatase Cytochrome P450 Endocrinology, November 1, 1999; 140(11): 5202 - 5210. [Abstract] [Full Text]

				J. F. Couse and K. S. Korach Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us? Endocr. Rev., June 1, 1999; 20(3): 358 - 417. [Abstract] [Full Text]

				N. J. Sarlis, S. J. Weil, and L. M. Nelson Administration of Metformin to a Diabetic Woman with Extreme Hyperandrogenemia of Nontumoral Origin: Management of Infertility and Prevention of Inadvertent Masculinization of a Female Fetus J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1510 - 1512. [Full Text]

				E. Y. Adashi and J. D. Hennebold Single-Gene Mutations Resulting in Reproductive Dysfunction in Women N. Engl. J. Med., March 4, 1999; 340(9): 709 - 718. [Full Text] [PDF]

				J. C. Lo, V. M. Schwitzgebel, J. B. Tyrrell, P. A. Fitzgerald, S. L. Kaplan, F. A. Conte, and M. M. Grumbach Normal Female Infants Born of Mothers with Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 930 - 936. [Abstract] [Full Text]

				J. P. Bilezikian, A. Morishima, J. Bell, and M. M. Grumbach Increased Bone Mass as a Result of Estrogen Therapy in a Man with Aromatase Deficiency N. Engl. J. Med., August 27, 1998; 339(9): 599 - 603. [Full Text] [PDF]

				C. R. Fisher, K. H. Graves, A. F. Parlow, and E. R. Simpson Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene PNAS, June 9, 1998; 95(12): 6965 - 6970. [Abstract] [Full Text] [PDF]

				C. Carani, K. Qin, M. Simoni, M. Faustini-Fustini, S. Serpente, J. Boyd, K. S. Korach, and E. R. Simpson Effect of Testosterone and Estradiol in a Man with Aromatase Deficiency N. Engl. J. Med., July 10, 1997; 337(2): 91 - 95. [Full Text] [PDF]

				S. Mesiano and R. B. Jaffe Developmental and Functional Biology of the Primate Fetal Adrenal Cortex Endocr. Rev., June 1, 1997; 18(3): 378 - 403. [Abstract] [Full Text]

				P. E. Mullis, N. Yoshimura, B. Kuhlmann, K. Lippuner, P. Jaeger, and H. Harada Aromatase Deficiency in a Female Who Is Compound Heterozygote for Two New Point Mutations in the P450arom Gene: Impact of Estrogens on Hypergonadotropic Hypogonadism, Multicystic Ovaries, and Bone Densitometry in Childhood J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1739 - 1745. [Abstract] [Full Text] [PDF]

				J. F. Sotos Overgrowth Clinical Pediatrics, December 1, 1996; 35(12): 635 - 648. [PDF]

				E. P. Smith, J. Boyd, G. R. Frank, H. Takahashi, R. M. Cohen, B. Specker, T. C. Williams, D. B. Lubahn, and K. S. Korach Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man N. Engl. J. Med., October 20, 1994; 331(16): 1056 - 1061. [Abstract] [Full Text]

				T. Yalcinkaya, P. Siiteri, J. Vigne, P Licht, S Pavgi, L. Frank, and S. Glickman A mechanism for virilization of female spotted hyenas in utero Science, June 25, 1993; 260(5116): 1929 - 1931. [Abstract] [PDF]

				A Elbrecht and R. Smith Aromatase enzyme activity and sex determination in chickens Science, January 24, 1992; 255(5043): 467 - 470. [Abstract] [PDF]